US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Omega Therapeutics Inc (OMGA)
Omega Therapeutics Inc (OMGA) ニュース

OMGA

Omega Therapeutics (OMGA)

Omega Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OMGA

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	20 : 00	GlobeNewswire Inc.	Omega Therapeutics To Participate In Two Upcoming Investor Conferences	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/29	20 : 00	GlobeNewswire Inc.	Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/08	20 : 00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/06	20 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/06	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/06	20 : 00	GlobeNewswire Inc.	Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress	NASDAQ:OMGA	Omega Therapeutics Inc
2024/04/23	20 : 00	GlobeNewswire Inc.	Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting	NASDAQ:OMGA	Omega Therapeutics Inc
2024/04/09	20 : 00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control	NASDAQ:OMGA	Omega Therapeutics Inc
2024/03/28	22 : 15	GlobeNewswire Inc.	Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update	NASDAQ:OMGA	Omega Therapeutics Inc
2024/03/06	21 : 00	GlobeNewswire Inc.	Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:OMGA	Omega Therapeutics Inc
2024/02/10	07 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMGA	Omega Therapeutics Inc
2024/02/10	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMGA	Omega Therapeutics Inc
2024/02/10	06 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMGA	Omega Therapeutics Inc
2024/01/06	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2024/01/03	06 : 05	GlobeNewswire Inc.	Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/12/12	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2023/12/05	06 : 00	GlobeNewswire Inc.	Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/28	09 : 01	PR Newswire (US)	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/21	20 : 00	PR Newswire (US)	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/21	06 : 00	GlobeNewswire Inc.	Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/13	21 : 00	GlobeNewswire Inc.	Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/09	21 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/09	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/09	21 : 00	GlobeNewswire Inc.	Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/08	06 : 00	GlobeNewswire Inc.	Omega Therapeutics to Participate in The Jefferies London Healthcare Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/31	20 : 00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/16	20 : 00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/12	05 : 00	GlobeNewswire Inc.	Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/05	05 : 00	GlobeNewswire Inc.	Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	NASDAQ:OMGA	Omega Therapeutics Inc
2023/09/27	06 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:OMGA

1 2 3 4 5 6 次へ >>

EndlessWebWorlds

Vontobel Financial Produ...

Grupo Media Capital Sgps

BNP Paribas Issuance

Digital World Exchange

Caesars Entertainment

Vontobel Financial Produ...

ExNetwork Community Token

FTP Sabrient Baker's Doz...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約